x
African Health Sciences
[contact-form-7 id="2459" title="Sidebar Form"]

  • 256(41)530021
  • info@africanhealthsciences.org
African Health Sciences
  • info@africanhealthsciences.org
  • Give Feedback
  • Home
  • About Us
  • Staff
  • Focus & Scope
  • For Authors
  • More Links
    • About The Journal
    • Latest Articles
    • Journal Archives
    • Our Events
    • Faq’s
  • Contact Us
Logo

Contact Info

  • P. O. Box 7072 Kampala, Uganda
  • +256(41)530021
  • info@africanhealthsciences.org
  • ISSN 1680-6905
  • <!--
  • -->

14Nov2017

commercially available quinine sulphate tablets

by admin,  0 Comments

Evaluation of the physicochemical equivalence of three brands of commercially available quinine sulphate tablets from South Western part of Nigeria

AI Adegbite, OM Adegbolagun

Abstract

Background: The relatively little resistance to quinine globally has led to an increase in its use in P. falciparum malaria especially in multi-drug resistant strains.

Objective: To evaluate the physicochemical and equivalency of three brands of quinine sulphate tablets available in South Western region of Nigeria.

Methods: The pharmaceutical and chemical equivalence of three brands of quinine sulphate tablets were assessed through the evaluation of some biopharmaceutical parameters and active drug content.

Results: All the brands complied with the official specification for uniformity of weight. Two of the brands (A & B) gave similar crushing strengths while the third brand (C) gave a much lower value. Similarly all the brands complied with the official specification of disintegration test but the obtained values were statistically different (p<0.05). The T70 obtained
from the dissolution rate profile was less than 45 minutes for the three brands, although A and B were not statistically different but C was statistically from A and B. The quinine content of brands B and C are within the official specification however brand A with percentage content of 110±1.3%w/w, is above the specification while it is statistically different from the other brands.

Conclusion: Brands B and C could be regarded as chemical equivalent, but they are not biopharmaceutical equivalents, on the other hand, brands A and B may be regarded as biopharmaceutical equivalents but not chemical equivalent.

 

Related posts:

Actual and perceived substance use of health science students

Sea-Change or Change Challenge

Antimicrobial susceptibility patterns

Recent Posts

  • Editor’s choice: Tackling infectious diseases, NCDs and sexual reproductivehealth issues as we enter our 24th year of remarkable growth
  • Preconception and contraceptive care for women living with HIV/AIDSattending antiretroviral treatment clinics in Lagos State, Nigeria
  • Effects of SNPs on TNF-α and IL-10 cytokine expression in TB and HIVpatients in the Capricorn district, Limpopo Province, South Africa
  • Prevalence of Schistosomiasis in a neglected community, South western Nigeria at two points in time, spaced three years apart
  • Review of Leishmaniasis in the Middle East and North Africa

Recent Comments

No comments to show.

Archives

  • April 2024
  • May 2019
  • April 2019
  • September 2018
  • August 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017

Categories

  • 2001 Issues
  • 2002 Issues
  • 2003 Issues
  • 2004 Issues
  • 2005 Issues
  • 2006 Issues
  • 2007 Issues
  • 2008 Issues
  • 2009 Issues
  • 2010 Issues
  • 2011 Issues
  • 2012 Issues
  • 2013 Issues
  • 2014 Issues
  • 2015 Issues
  • 2016 Issues
  • 2017 Issues
  • 2018 Issues
  • 2019 Issues
  • 2024 Issues
  • Articles
  • December issue
  • December Release
  • June Issue
  • June Release
  • March Issue
  • March Issue
  • March Release
  • News
  • number / volume 2
  • number /volume 1
  • number /volume 1
  • number /volume 1 2008
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2 special Issue
  • number 2 special Issue 2
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 4
  • number 4
  • number 4
  • number 4
  • number 4
  • number 4
  • number/ volume 3 2008
  • number/ volume 4 2008
  • number/volume 1
  • number/volume 1
  • number/volume 2
  • number/volume 2
  • number/volume 2 2008
  • number/volume 3
  • number/volume 3
  • number/volume 3
  • number/volume 4
  • number/volume1
  • September Issue
  • September Release
  • Special Edition
  • special Issue
  • Uncategorized
  • Vol. 24 No. 1 (2024)
  • volume 1
  • volume 1
  • volume 1
  • volume 2
  • volume 2
  • volume 2
  • volume 2
  • volume 2
  • volume 3
  • volume 3
  • volume 3
  • volume 3
  • volume 4
  • volume 4
  • volume 4
  • volume 4
  • volume1

Categories

  • 2001 Issues
  • 2002 Issues
  • 2003 Issues
  • 2004 Issues
  • 2005 Issues
  • 2006 Issues
  • 2007 Issues
  • 2008 Issues
  • 2009 Issues
  • 2010 Issues
  • 2011 Issues
  • 2012 Issues
  • 2013 Issues
  • 2014 Issues
  • 2015 Issues
  • 2016 Issues
  • 2017 Issues
  • 2018 Issues
  • 2019 Issues
  • 2024 Issues
  • Articles
  • December issue
  • December Release
  • June Issue
  • June Release
  • March Issue
  • March Issue
  • March Release
  • News
  • number / volume 2
  • number /volume 1
  • number /volume 1
  • number /volume 1 2008
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 1
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2
  • number 2 special Issue
  • number 2 special Issue 2
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 3
  • number 4
  • number 4
  • number 4
  • number 4
  • number 4
  • number 4
  • number/ volume 3 2008
  • number/ volume 4 2008
  • number/volume 1
  • number/volume 1
  • number/volume 2
  • number/volume 2
  • number/volume 2 2008
  • number/volume 3
  • number/volume 3
  • number/volume 3
  • number/volume 4
  • number/volume1
  • September Issue
  • September Release
  • Special Edition
  • special Issue
  • Uncategorized
  • Vol. 24 No. 1 (2024)
  • volume 1
  • volume 1
  • volume 1
  • volume 2
  • volume 2
  • volume 2
  • volume 2
  • volume 2
  • volume 3
  • volume 3
  • volume 3
  • volume 3
  • volume 4
  • volume 4
  • volume 4
  • volume 4
  • volume1

Archives

  • April 2024
  • May 2019
  • April 2019
  • September 2018
  • August 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017

Tags

Achives Latest News


ISSN 1680-6905

  • P. O. Box 7072 ,Kampala, Uganda
  • Call Us: 256(41)530021
  • info@africanhealthsciences.org

Latest Activities

Usefull Link

  • About AHS
  • Services
  • Focus & Scope
  • Our Articles
  • Contact Us

Subscribe

For research updates from African Health Sciences, sign up now!

[contact-form-7 id="1620" title="Subscribe"]

African Health Sciences © All Right Reserved